Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypertension and diabetes].

B Bouhanick1, S Laboureau-Soares Barbosa, M Marre

  • 1Service de médecine B, 4, rue Larrey, 49033 Angers.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.

Diabetes & metabolism·2020
Same author

Relationship between renal capacity to reabsorb glucose and renal status in patients with diabetes.

Diabetes & metabolism·2020
Same author

Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).

Diabetes & metabolism·2019
Same author

Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. cohort.

Diabetes & metabolism·2019
Same author

Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.

Diabetes & metabolism·2019
Same author

No prognostic role of a GWAS-derived genetic risk score in renal outcomes for patients from French cohorts with type 1 and type 2 diabetes.

Diabetes & metabolism·2018

Hypertension management is crucial for diabetic patients. Optimal blood pressure control, alongside lifestyle changes, reduces cardiovascular risks and complications in both type 1 and type 2 diabetes mellitus.

Area of Science:

  • Cardiology
  • Endocrinology
  • Nephrology

Context:

  • Hypertension frequently co-exists with diabetes mellitus, impacting patient prognosis.
  • Pathophysiology of hypertension differs between type 1 and type 2 diabetes.
  • Hypertension exacerbates macrovascular and microvascular complications in diabetic individuals.

Purpose:

  • To outline the distinct physiopathology of hypertension in type 1 and type 2 diabetes.
  • To emphasize the importance of optimal blood pressure control in managing diabetic complications.
  • To highlight recommended antihypertensive strategies and lifestyle modifications.

Summary:

  • In type 1 diabetes, hypertension often stems from nephropathy, with Angiotensin Converting Enzyme (ACE) inhibitors recommended.

Related Experiment Videos

  • In type 2 diabetes, hypertension is typically essential, linked to insulin resistance and metabolic syndrome. ACE inhibitors, diuretics, and beta-blockers are first-line options.
  • Optimal blood pressure target is ≤140/80 mmHg, with therapeutic associations often necessary.

    • Impact:

    • Effective blood pressure management is vital for improving outcomes in diabetic patients.
    • Addressing cardiovascular risk factors like obesity and sedentary lifestyle is essential.
    • Tailored antihypertensive treatments, considering diabetic type and comorbidities, are key to preventing complications.